SureTrader Advertisement PRTC
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: BigKahuna, BooDog, noretreat, TOB, sox040713, TheHound
Search This Board:
Last Post: 5/31/2016 3:30:08 PM - Followers: 705 - Board type: Free - Posts Today: 93

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
About Cellceutix: 
Headquartered in Beverly, Massachusetts, Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in multiple diseases. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin concluded a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center, and Cellceutix is now preparing its FDA application for a Phase 2 ovarian cancer study. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is in a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention of Oral Mucositis in patients with head and neck cancer. Brilacidin-OM, a defensin mimetic compound, has shown in an animal model to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is in a Phase 2 trial. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s lead antibiotic, Brilacidin, has completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the FDA-approved seven-day dosing regimen of daptomycin. Brilacidin has the potential to be a single-dose therapy for certain multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna. More information is available on the Cellceutix web site atwww.cellceutix.com.

Management:  http://cellceutix.com/team/

Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/

 

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

http://eccmid.meetingexpert.net/ECCMID_546/poster_122533/program.aspx/anchor122533

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

http://eccmid.meetingexpert.net/ECCMID_546/poster_122353/program.aspx

 
SEC Filings (CIK:0001355250):  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:

EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275
 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
CTIX News: Quarterly Report (10-q) 05/09/2016 05:57:46 PM
CTIX News: Current Report Filing (8-k) 04/08/2016 10:04:54 AM
CTIX News: Current Report Filing (8-k) 03/31/2016 06:24:52 AM
CTIX News: Quarterly Report (10-q) 02/08/2016 04:03:50 PM
CTIX News: Amended Statement of Ownership (sc 13g/a) 01/27/2016 09:57:11 AM
PostSubject
#148787  Sticky Note Cellceutix Phase 2 Trial of Prurisol for Mild sox040713 05/24/16 02:18:08 PM
#148662  Sticky Note Achieving CTIX Potential Catalysts and Past Milestones BooDog 05/24/16 11:06:48 AM
#144039  Sticky Note $CTIX ---> (.)(.) <--- CTIX$ TheHound 03/31/16 03:44:16 PM
#139659  Sticky Note (repost) Court Filings (Zagami vs Cellceutix, 1:15-cv-07194) slcimmuno 02/11/16 08:25:42 AM
#133344  Sticky Note We are looking forward ... to our fiscal noretreat 12/14/15 02:58:59 PM
#117003  Sticky Note Cellceutix released efficacy data for Kevetrin, its cancer TOB 08/09/15 03:05:24 PM
#149617   Leo probably sold 150,000 shares today MXAMDUD 05/31/16 03:54:29 PM
#149616   Thanks Sox! And as BK has pointed out TheHound 05/31/16 03:30:08 PM
#149615   Great post, Eric! With two presentations in June, sox040713 05/31/16 03:24:42 PM
#149614   Thanks,Sox-I mean MR.SOX- you are doing a really winnail 05/31/16 03:24:06 PM
#149613   I'll be in Malibu so I'm going to luxe 05/31/16 03:21:30 PM
#149612   I hope you can make it and give sox040713 05/31/16 03:19:58 PM
#149611   Both fast track and priority review will be sox040713 05/31/16 03:17:15 PM
#149610   Sure hope you can make it Karin and tombrady12nh 05/31/16 03:16:34 PM
#149609   I see $CTIX listed as a presenting company KarinCA 05/31/16 03:12:14 PM
#149608   Yes. June 7, 1:00 P.M. (Track 3): Louis Rukeyser 05/31/16 02:41:46 PM
#149607   i'd love to help u out but my TheHound 05/31/16 02:37:22 PM
#149606   NEWS (nothing too major, but news nonetheless)!!! ericseb2003 05/31/16 02:34:03 PM
#149605   Many posters here have said a deal will greatimes 05/31/16 02:25:32 PM
#149603   B and QIDP At one time someone said that Amatuer17 05/31/16 02:07:39 PM
#149601   5-31-16 $CTIX ~ Cellceutix Corp. Due Diligence Report TheHound 05/31/16 01:38:36 PM
#149600   Well articulated! I think there are only two luxe 05/31/16 01:22:00 PM
#149599   The upcoming (maybe this week) dismissal with prejudice Golfguru03 05/31/16 01:20:18 PM
#149598   I appreciate your firm optimistic views on the centillion 05/31/16 01:00:25 PM
#149595   Agree with Dane...CTIX will move like the other Justfactsmam 05/31/16 12:46:43 PM
#149593   Gone are the days where a company's Q-by-Q tykundegex 05/31/16 12:34:06 PM
#149590   Leo is sure a great friend to all Jhawker 05/31/16 12:12:47 PM
#149589   Wow the good news regarding P just keeps Jhawker 05/31/16 12:09:46 PM
#149587   amen. Leo is no friend to shareholders MXAMDUD 05/31/16 11:57:31 AM
#149586   Leo you are not fooling shareholders anymore , BobbyKIrk 05/31/16 11:55:34 AM
#149585   More than ever... ericseb2003 05/31/16 11:52:35 AM
#149584   Nuke 'em. incubus-now 05/31/16 11:51:55 AM
#149583   Sales probably told Leo to sell. Detonate 05/31/16 11:14:54 AM
#149580   http://cellceutix.us2.list-manage.com/track/click?u=9ed1a6b082ae8962468007971&id stocker11 05/31/16 10:56:35 AM
#149578   smells like Leo is possibly selling MXAMDUD 05/31/16 10:35:16 AM
#149577   Price action? Not sure I follow... The stock Rdunn88 05/31/16 10:33:11 AM
#149576   nope. price action says there is more MXAMDUD 05/31/16 10:27:13 AM
#149575   BooDog, I do (too) smell some subtle manipulation I Need Help 05/31/16 10:26:56 AM
#149574   By not mentioning a partnership tells me there's Rdunn88 05/31/16 10:24:43 AM
#149573   lol, simple really. 3 pr's saying pretty much BooDog 05/31/16 10:20:24 AM
#149572   I know the negative conditioning is working when TheDane 05/31/16 10:19:08 AM
#149571   Alas. Two arrows shot. Stock still dead. What's TheDane 05/31/16 10:17:01 AM
#149570   A thought crossed my mind on recent trade: I Need Help 05/31/16 10:15:11 AM
#149569   This is an absolute love / hate relationship Vlady 1 05/31/16 10:13:54 AM
#149568   sitting on 1.47 bid. won't fill MXAMDUD 05/31/16 10:13:05 AM
#149567   Good info in today's PR, though more reassuring frrol 05/31/16 10:11:15 AM
#149566   Very nice play on words. PR and CPR Amatuer17 05/31/16 10:05:25 AM
#149565   10,000 shares have been traded today. Your speculation nerby 05/31/16 10:05:16 AM
#149564   maybe Leo is even selling his shares? could be MXAMDUD 05/31/16 10:03:23 AM
#149563   I agree this PR was not needed. tombrady12nh 05/31/16 09:59:29 AM
#149562   LEO please no more of these PR's. EOM JTORENCE 05/31/16 09:55:24 AM
#149561   I think the CEO is confusing PR with FarmaZutical 05/31/16 09:55:18 AM
#149560   And there is your response to the PR Vlady 1 05/31/16 09:52:55 AM
#149559   down 5% MXAMDUD 05/31/16 09:51:22 AM
#149558   not halted just no positive interest. tanking MXAMDUD 05/31/16 09:50:54 AM
#149557   Are we halted,..? I see NO VOLUME! cabel 05/31/16 09:45:09 AM
PostSubject